Therapeutic Expert Council

  • Professor, Pulmonary/Critical Care
  • Chief, Pulmonary South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital

Dr. Antonio R. Anzueto is Professor of Pulmonary/Critical Care in the Department of Medicine at the University of Texas Health, San Antonio and Chief in the Pulmonary Section at The South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division in San Antonio. He also serves as the Medical Director of the Respiratory Therapy Department and the Pulmonary Function Laboratory.


Dr. Anzueto received his medical degree from the Universidad de San Carlos de Guatemala in Guatemala City, Guatemala and completed his residency in internal medicine at Hospital San Juan de Dios in Guatemala City, Guatemala, and then at the University of Texas, San Antonio, where he also completed a fellowship in critical care medicine and pulmonary diseases. He is a Fellow of the European Respiratory Society and the American Thoracic Society and currently serves on the editorial board of the American Journal of Respiratory and Critical Care Medicine, the American College of CHEST Physicians Journal, the COPD Journal, and the Respiratory Research Journal. Dr. Anzueto has published over 300 manuscripts in highly rated medical journals. He has also received multiple awards, such as Teacher of the Year from the University of Texas Health at San Antonio.

  • Professor of Medicine, Harvard Medical School
  • Director, COPD Center at Brigham and Women’s Hospital

Dr. Bartolome R. Celli is one of the world’s leading experts in the area of pulmonary medicine, with a particular emphasis on Chronic Obstructive Pulmonary Disease (COPD). Dr. Celli currently serves as Professor of Medicine at Harvard Medical School and Director of the COPD Center at Brigham and Women’s Hospital in Boston, MA.


His notable past positions include serving as the Chief of Pulmonary Services and the Director of the Intensive Care Unit for Hospital Coromoto in Maracaibo, Venezuela; Director of Pulmonary Physiology Research for the Boston University Medical Center; Medical Director for the Pulmonary Function Laboratory for the Boston V.A. Medical Center; the Chief of Pulmonary and Critical Care for Boston VA Medical Center and the St. Elizabeth’s Medical Center in Boston, MA; Assistant and Associate Professor of Medicine at Boston University School of Medicine; and Professor of Medicine at Tufts University School of Medicine in Boston, MA.


Dr. Celli is a prolific scholar who has authored >280 peer-reviewed articles, >350 scientific abstracts, and several books related to COPD. Dr. Celli’s research has been featured in highly prestigious journals including The New England Journal of Medicine, CHEST, The Lancet Respiratory Medicine, COPD, Respiratory Medicine, and the American Journal of Respiratory and Critical Care Medicine. As part of his commitment to scholarly contributions, Dr. Celli has served as an Associate Editor for CHEST, the Journal of COPD and the Archives of Bronchoneumologia. He also serves as a reviewer for top-tiered medical journals such as the New England Journal of Medicine, The Lancet, CHEST, Annals of Internal Medicine, Journal of COPD, Respiratory Research, and Respiratory Care. Additionally, Dr. Celli has been a passionate educator and mentor to the next generation.

  • Professor Emeritus, Medicine & Physiology
  • Former Medical Director, UCLA COPD Program, Lung Volume Reduction Surgery Program, and Clinical Exercise Physiology Laboratory

Dr. Christopher B. Cooper is an award-winning Professor Emeritus of Medicine and Physiology at the David Geffen School of Medicine at UCLA, and a world-renowned leader in respiratory medicine. He has over 40 years of clinical practice experience, specializing in respiratory diseases and critical care medicine.

Dr. Cooper served as Medical Director of the UCLA COPD Program, Medical Director of the Lung Volume Reduction Surgery Program, and Medical Director of the Clinical Exercise Physiology Laboratory at UCLA Medical Center. He trained at the St. Thomas’ Hospital Medical School at the University of London, England, obtaining his B.Sc. in Physiology in 1973 and graduating in medicine in 1976 (conferred as MB, BS). Dr. Cooper completed his postgraduate training in general internal medicine and specialist training in pulmonary and critical care medicine in England at St. Thomas’ Hospital, London and the University of Sheffield. He obtained his doctoral thesis (conferred as MD) on methods of rehabilitation in chronic obstructive pulmonary disease in 1991 and a master’s degree in Biomathematics and Clinical Research in 2013. He is a member of the British Thoracic Society, American Thoracic Society and European Respiratory Society. His publications include over 300 peer reviewed original research articles, and he is author of a popular book entitled “Exercise testing and interpretation: A practical approach,” first published in English by Cambridge University Press in 2001 and now translated into three other languages.

  • Medical Director, COPD360
  • Clinical Associate Professor of Medicine, UNC
  • Former Group Director, GSK Clinical Development and Medical Affairs

Dr. Courtney Crim is the COPD360 Medical Director for the COPD Foundation. In this role he supports COPD360Net, the Foundation’s initiative to facilitate, review, and expedite clinical trials for new therapies and digital health tools while also providing support to the Foundation’s COPD360 Coach program. Dr. Crim is also Clinical Associate Professor of Medicine in Pulmonary and Critical Care Medicine at the University of North Carolina-Chapel Hill.


Most recently he served as Group Director in Clinical Development in Respiratory Clinical Sciences at GlaxoSmithKline. He has over 20 years of experience designing Phase 2–4 clinical trials that encompassed developing new medical entities. Earlier in his academic career, he was a member of the U.S. Food and Drug Administration Pulmonary and Allergy Drug Advisory Committee and has also presented submissions for drug approval at U.S., European, and other country regulatory agencies.


Dr. Crim holds a Bachelor of Science degree in chemistry from the University of Michigan and a Doctor of Medicine degree from the University of Michigan Medical School. He completed post-graduate training in internal medicine at Baylor College of Medicine in Houston and Henry Ford Hospital in Detroit, with subspecialty training in pulmonary and critical care medicine at the University of Michigan. He is certified by the American Board of Internal Medicine in internal medicine, pulmonary diseases, and critical care medicine. He serves as a mentor for minority medical students at the University of Michigan Medical School and is currently liaising with a local university and a philanthropic organization to develop an immersion program for underrepresented minorities at a local high school to foster interest in science and medicine.

  • Consultant Physician and Honorary Professor of Respiratory Medicine, University of Exeter
  • Honorary Professor of Respiratory Medicine, Observational and Pragmatic Research Institute

Professor Halpin is Consultant Physician and Honorary Professor in Respiratory Medicine at the University of Exeter. He was appointed as a Consultant in 1994. He has a busy clinical practice and for 13 years he was Clinical Lead for the Department in Exeter, overseeing the growth in its clinical and research activity. He is also Honorary Professor of Respiratory Medicine at the Observational and Pragmatic Research Institute (OPRI) in Singapore.


Dr. Halpin is a member of the Board of Directors of the Global Initiative on Obstructive Lung Diseases (GOLD) and of the GOLD Science Committee. He was the Chairman and Clinical Expert for the COPD Guideline Development Group of the National Institute of Clinical Excellence (NICE) in the UK. He studied at Oxford University (first class honours) and St. Thomas Hospital Medical School, qualifying in 1986. He was awarded an MRC scholarship to undertake a D.Phil. in the Department of Human Anatomy at Oxford University, between his pre-clinical and clinical training. He trained in respiratory medicine at the Brompton Hospital in London.


Dr. Halpin is a Fellow of Royal College Physicians, and a Member of the BTS, ERS & ATS. He has served on various BTS committees. In 2018, he was elected as a Fellow of ERS in recognition of lifetime excellence and contributions to research, education, and clinical leadership in respiratory medicine. His research is focused on clinical aspects of COPD and asthma. He has published extensively and frequently gives presentations on COPD and asthma at lectures and meetings around the world. He was an Associate Editor of Thorax and is on the editorial board of American Journal of Respiratory & Critical Care Medicine as well as several other journals and is a peer reviewer for many others.

  • Chief, Division of Pulmonary/Critical Care
  • Global Obstructive Lung Disease Scientific Committee

Dr. MeiLan K. Han is Professor of Medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan Health. She received her medical degree from the University of Washington in Seattle, Washington and completed her residency in Internal Medicine and fellowship in Pulmonary and Critical Care Medicine at the University of Michigan.


Dr. Han serves on the scientific advisory committees for both the COPD Foundation and American Lung Association, the board for the COPD Foundation, and is as a spokesperson for the American Lung Association. She is a member of the Global Obstructive Lung Disease scientific committee, which is charged with developing an internationally recognized consensus statement on COPD diagnosis and management. Dr. Han is also the author of a book on lung health for the public, “Breathing Lessons.”

  • Nationally recognized Pulmonary disease Research Investigator
  • Tenured Professor, University of Michigan

Dr. Moore joined the faculty at the University of Michigan as a Research Investigator in 1997 and has risen through the ranks where she now holds the position of Professor with tenure. She received her B.A. in Microbiology from the University of Texas at Austin in 1986 and her PhD in Immunology from the University of Texas Southwestern Medical School in Dallas in 1992. She performed post-doctoral studies at UT Southwestern from 1992-1994, and then at Stanford University from 1994-1997.


Dr. Moore has been recognized for her research accomplishments both nationally and locally. Her interests broadly include lung immunology and host defense. In 2014, she received the “Recognition Award for Scientific Accomplishments” from the American Thoracic Society and was inducted into the University of Michigan League of Research Excellence. She received the Rackham Distinguished Graduate Mentoring Award in 2019. She directed the Graduate Program in Immunology from 2012 to 2019 when she stepped down to accept the role of Interim Chair of the Department of Microbiology and Immunology. Dr. Moore was named permanent chair of Microbiology and Immunology in 2021.

  • Professor, Division of Pulmonary, Critical Care and Sleep Medicine
  • Former SVP, AstraZeneca IMED Early Clinical Development

Dr. Stephen Rennard is a Professor in the Division of Pulmonary, Critical Care and Sleep Medicine Division at the University of Nebraska Medical Center. He also serves as medical director of the Alpha 1 Foundation Therapeutic Development Network and as president of Great Plains Biometrix, LLC.

Dr. Rennard completed undergraduate training in Folklore and Mythology at Harvard College, obtained his medical degree from Baylor College of Medicine, trained in internal medicine at Washington University, and then did research and pulmonary training at the National Institutes of Health.  He was Chief of the Pulmonary Division at the University of Nebraska Medical Center from 1984 until 1997 and remains a professor at the University.  He has been a fellow at Homerton College, University of Cambridge, since 2016 and a fellow of the National Strategic Research Institute since 2021.

Dr. Rennard has received numerous awards and served on multiple boards including the American Lung Association, American Thoracic Society, and the COPD Foundation. He was an author of the Foundation’s Guide for the Diagnosis and Management of COPD. His laboratory research has focused on mechanisms of tissue remodeling and repair and clinical studies particularly related to chronic obstructive pulmonary disease and smoking cessation. 


From August 2015 through November 2019, Dr. Rennard worked at AstraZeneca, Cambridge, UK. Starting as Chief Clinician Scientist in the Clinical Discovery Unit of Early Clinical Development (ECD), he became head of that unit in 2016, was appointed head of IMED Early Clinical Development in November 2017, and was promoted to Senior Vice President in 2018.

  • Division Chief, Pulmonary/Critical Care/Sleep Medicine
  • Consultant, Global Obstructive Lung Disease Guidelines

Dr. Sanjay Sethi is a Professor of Medicine at the University of Buffalo (UB), SUNY, where he is Chief of the Pulmonary/Critical Care/Sleep Medicine Division, Assistant Vice President for Health Sciences, Director of the Clinical Research Office and Deputy Director of the UB Clinical and Translational Science Institute. His main research interests include chronic obstructive pulmonary disease and respiratory infections, specifically focused on exacerbations, new therapeutics and innate lung defense. He has conducted and led bench, translational and clinical research including multiple single and multi-site clinical trials. Dr Sethi has co-authored more than 240 research articles, reviews and book chapters in many peer-reviewed medical journals including New England Journal of Medicine, JAMA, Science Translational Medicine, PNAS and American Journal of Respiratory and Critical Care Medicine, that has been widely cited and has a current Google scholar h-index of 74. His current research funding includes grants from the NIH, DOD, VA and several pharmaceutical companies. He is a member of the editorial board for several publications. He was a member of the lung cellular, molecular, and immunobiology study section of the National Institutes of Health (NIH) and the Pulmonary study section of the VA and is an ad hoc reviewer for several North American and International research funding agencies.


Dr. Sethi is currently active in several professional organizations including the American Thoracic Society where he has chaired the Clinical Problems program committee and the Clinical Problems Assembly. He has served as a consultant on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for COPD and was a member of the Department of Veterans Affairs and Department of Defense COPD Guideline Development Committee. Additionally, he is a distinguished speaker presenting papers both nationally and internationally, many with COPD and Respiratory Infections as the primary focus.